The first cases of “AIDS” reported by the CDC were based on pneumocystis pneumonia infections of previously healthy gay men. This infection is caused by the normally harmless fungus Pneumocystis jirovecii, but the infection became severe in these individuals. Instead of asking why these infections were more severe in these individuals, medical authorities dismissed further inquiry into underlying factors. No attempt was made to investigate these cases through the perception of the terrain theory of disease, which addresses the whole individual and the conditions that breed disease. By only seeing disease through the perception of the germ theory, medical authorities played right into the hands of the pharmaceutical industry and snuffed out scientific progress on the matter.
Controversy behind the emergence of the term AIDS and its sole causative agent, HIV
By September of 1982, the medical establishment coined a new medical condition called AIDS (acquired immunodeficiency syndrome). This umbrella term was used as a cover for many different types of infections, malnutrition, the negative effects of immunosuppressant drugs and other personal health decisions that damage the blood. The underlying causes exacerbating immunosuppression could easily be ignored for individuals who struggled with these different infections, because the umbrella term AIDS covered up the underlying causes of their health conditions.
By 1982, medical authorities claimed that AIDS had affected 335 people, killing 136 of them. Remarkably in 1983, scientists discovered human immunodeficiency virus type 1 (HIV-1). By 1984, HIV was attributed as the sole cause of AIDS, and many medical coverups began from here. Because the condition overwhelmingly affected men who practiced homosexuality, the disease was often referred to as gay-related immune deficiency, or GRID.
Since then, billions of dollars in research money has been awarded to scientists who uphold the HIV-AIDS connection. Today, medical authorities continue to postulate that HIV is the sole cause of AIDS, and discussion about the underlying factors of immunosuppression are disregarded as conspiracy theory. One of the first books to be censored was “The Health Scandal” written by Dr. Vernon Coleman in 1988.
"The Health Scandal" contained a chapter describing the truth about AIDS, which led to the book being censored.
Censored book “The Health Scandal” asks the tough questions about AIDS
Dr. Vernon Cole argues that AIDS should be viewed more as a blood-related disorder rather than a sexually transmitted disease that affects specific populations, like drug users and gay men. Cole asserts that the AIDS industry has grown into a vast bureaucracy, employing thousands and consuming enormous amounts of taxpayer money without delivering significant breakthroughs or saving lives.
Cole argues that the changing criteria for diagnosis have inflated the number of reported AIDS cases, which serves to justify ongoing funding and research efforts. From 2011 to 2021, there were approximately 400,000 AIDS patients diagnosed in the U.S. This is the result of expanding diagnostic criteria, which conceals the underlying causes of immunosuppression. This manipulation of statistics has led to allegations that many deaths attributed to AIDS are, in fact, from other blood and fungal infections, hospital-acquired infections or other common respiratory infections like tuberculosis or pneumonia.
Cole writes that AIDS may not exist as a unique disease but rather as a collection of previously identified conditions and immune system failures. By not getting to the bottom of these immune system failures, medical authorities have misled the public, putting people's health at risk over several decades.
Cole suggests that the focus of medical and public health authorities should shift toward bolstering the immune system through lifestyle changes and nutritional support rather than adhering strictly to the helpless HIV/AIDS paradigm. This paradigm has followed a 50-year pattern of Big Pharma covering up symptoms, ignoring root causes and developing products that have a potential for high sales, while creating disease labels that require long term dependence on pharmaceutical drugs.
Sources include:
Please contact us for more information.
